Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation
ConclusionsIn this small series of patients, rATG appears a promising treatment for unresponsive cAMR. Further evaluation, including earlier introduction of rATG, is warranted.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Allergy & Immunology | Kidney Transplant | Kidney Transplantation | Pediatrics | Prednisolone | Rituxan | Transplant Surgery | Transplants | Urology & Nephrology | Velcade